Abstract:BACKGROUND:Primary glomerular disease (PGD) is the leading cause of end-stage renal disease (ESRD) in China. With the development of socioeconomic status of Chinese people in the last two decades, PGD in ESRD is intent to decrease. However, whether this affects the spectrum of PGD is not clear. The aim of the current study is to investigate the changing spectrum of PGD in China.METHODS:The records of 5398 consecutive native renal biopsies performed in adults (>or=14 years of age) in our centre between 1993 and 2007 were retrospectively analysed. The criteria for renal biopsy and pathologic diagnosis were kept unchanged. The patients were grouped according to a 5-year interval, 1993-97 (period 1), 1998-2002 (period 2) and 2003-07 (period 3). Then they were divided into four groups according to age for stratified analysis: 14-24 years, 25-44 years, 45-59 years and the elderly (>or=60 years).RESULTS:Three thousand, three hundred and thirty-one patients were diagnosed with PGD. PGD remained the most common renal disease, accounting for 65.9%, 57.7% and 63.2% in period 1, 2 and 3, respectively, without any significant difference. The proportion of elder patients increased significantly from 0% in 1993 to 9.1% in 2007 (P < 0.001). Within 1993-97, the leading PGD was IgA nephropathy (50.7%), followed by non-IgA MsPGN (19.9%), membranous nephropathy (MN) (13.3%) and minimal change disease (MCD) (6.3%), while within 2003-07, the most common PGD was still IgAN (58.2%), but followed by MN (14.3%), MCD (13.4%) and non-IgA MsPGN (7.0%). The age-adjusted frequency of IgAN and MCD increased significantly from period 1 to period 3 (P < 0.01 and P < 0.001, respectively), while that of non-IgA MsPGN, EnPGN and MPGN decreased significantly (P < 0.001, P < 0.01 and P < 0.05, respectively). There was no significant change in the age-adjusted frequency of FSGS, MN and CreGN during the study period. However, when patients were stratified by age, a sixfold increase in frequency of FSGS was identified in the 14- to 24-year group (P < 0.01).CONCLUSIONS:The spectrum of primary glomerulonephritis has changed within the last 15 years. The relative frequency of non-IgA MsPGN, EnPGN and MPGN decreased significantly, while that of MCD and IgA nephropathy increased significantly. The relative frequency of FSGS increased significantly in younger patients.

Manifestations De La Goutte Chez 9 754 Patients D’un Centre Clinique Chinois : Étude Observationnelle Sur 10 Ans

Trends in the manifestations of 9754 gout patients in a Chinese clinical center: A 10-year observational study

Current Pubertal Development in Chinese Children and the Impact of Overnutrition, Lifestyle, and Perinatal Factors.

Prevalence and Risk Factors of Hyperuricaemia in Non-Obese Chinese: a Single-Centre Cross-Sectional Study

Clinical characteristics of adolescent-onset gout in Chinese: A hospital-based cross-sectional study

Trend dynamics of gout prevalence among the Chinese population, 1990-2019: A joinpoint and age-period-cohort analysis

The prevalence of premature thelarche in girls and gynecomastia in boys and the associated factors in children in Southern China

Changes in the Diagnosis of Glomerular Diseases in East China: a 15-Year Renal Biopsy Study

Patterns of Pediatric and Adolescent Gynecologic Problems in China: A Hospital-Based Retrospective Study of 97,252 Patients

Secular trend of gout incidence in the UK: an age-period-cohort analysis

The Changing Spectrum of Primary Glomerular Diseases Within 15 Years: a Survey of 3331 Patients in a Single Chinese Centre.

Clinicopathological Features and Prognosis of Chinese Patients with Acute Post‐streptococcal Glomerulonephritis

Prevalence and risk factors of hyperuricemia and gout: a cross-sectional survey from 31 provinces in mainland China

Classification of patients with gout and their clinical features

Prevalence and Correlates of Hyperuricemia in the Middle-Aged and Older Adults in China

The prevalence of gout and related factors in community population

The prevalence of gout in mainland China from 2000 to 2016: a systematic review and meta-analysis

Global, Regional, and National Prevalence of Gout From 1990 to 2019: Age-Period-Cohort Analysis With Future Burden Prediction

Illness perception and treatment experience in patients with gout: a descriptive qualitative study

Prevalence and Related Factors of Hyperuricaemia in Chinese Children and Adolescents: a Pooled Analysis of 11 Population-Based Studies

A Cross-Sectional Study on Associated Diseases in Patients with Gout and Their Diagnoses and Therapy